A detailed history of Capital Investment Counsel, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Investment Counsel, LLC holds 21,182 shares of ABT stock, worth $2.47 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
21,182
Previous 30,555 30.68%
Holding current value
$2.47 Million
Previous $3.47 Billion 36.62%
% of portfolio
0.43%
Previous 0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$100.73 - $112.44 $944,142 - $1.05 Million
-9,373 Reduced 30.68%
21,182 $2.2 Billion
Q1 2024

Aug 14, 2024

BUY
$109.52 - $120.96 $334,693 - $369,653
3,056 Added 11.11%
30,555 $3.47 Billion
Q4 2023

Aug 14, 2024

BUY
$90.19 - $110.4 $2.48 Million - $3.04 Million
27,499 New
27,499 $3.03 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital Investment Counsel, LLC Portfolio

Follow Capital Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, LLC with notifications on news.